INFAI-news

Aktuelle Studien

Aktuell führt INFAI folgende klinische Studien durch.

Study PPI; Eudra CT Number: 2017-001369-25
The Sensitivity and Specificity in Helicobacter Pylori Positive and Negative Patients with Dyspesia Taking Proton Pump Inhibitors. Sponsor: INFAI

Study: Gastromotal; Eudra CT Number: 2011-002782-38
Gastromotal 1-¹³C-Caprylic Acid breath test in the diagnosis and evaluation of therapeutic outcome in patients with dyspeptic symptoms and delayed emptying. Sponsor: INFAI

Study HEAT; Eudra CT Number: 2011-003425-96
Helicobacter eradication to prevent ulcer bleeding in aspirin users: a large simple randomised controlled trial (HEAT). Sponsor: University of Nottingham

Hauptsitz INFAI GmbH

Riehler Straße 36
50668 Köln, Deutschland

Telefon: +49 221 880 44-3
Telefax: +49 221 880 44-55
24H - NOTRUFNUMMER:
+49 177 33 49 660
E-Mail: mail@infai.de

F&E INFAI

Universitätsstraße 136
44799 Bochum, Deutschland

Telefon: +49 234 971130
Telefax: +49 234 9711325
E-Mail: mail@infai.de

Produktion INFAI

An der Kohlenbahn 39
58135 Hagen, Deutschland

Copyright 2020 INFAI GmbH ©  All Rights Reserved